Developments in T cell based cancer immunotherapies /

This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects...

Full description

Saved in:
Bibliographic Details
Group Author: Ascierto, Paolo A. Paolo Antonio; Stroncek, David F; Wang, Ena
Published: Humana Press,
Publisher Address: Cham :
Publication Dates: [2015]
Literature type: Book
Language: English
Series: Cancer drug discovery and development,
Subjects:
Summary: This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification or reprogramming to increase their ability to survive and expand when adoptively transferred back t
Carrier Form: xv, 305 pages : illustrations (some color) ; 26 cm.
Bibliography: Includes bibliographical references and index.
ISBN: 9783319211664
3319211668
Index Number: RC261
CLC: R730.5
Call Number: R730.5/D489
Contents: 1 New insight of peptide vaccination in cancer immunotherapy -- 2 The determinants of T cell function for effective anticancer vaccine -- 3 T cell fate in the tumor microenvironment -- 4 T cell receptor avidity and affinity and tumor specific TCR engineer -- 5 Host genetic variation and somatic alteration associated with favorable or compromised T cell function -- 6 Production of Clinical T Cell Therapies -- 7 Clinical success of adoptive cell transfer therapy using tumor infiltrating lymphocytes.-8 Harnessing stem cell-like memory T cells for adoptive cell transfer therapy of cancer -- 9 T